PHASE I AND PHARMACOKINETIC TRIAL OF PTC299 IN PEDIATRIC PATIENTS WITH REFRACTORY OR RECURRENT CNS TUMORS: A PBTC STUDY

被引：0
|
作者：
Packer, Roger J. [1 ]
Rood, Brian R. [1 ]
Onar-Thomas, Arzu [2 ]
Goldman, Stewart [3 ]
Fisher, Michael J. [4 ]
Smith, Christopher [2 ]
Boyett, James [2 ]
Kun, Larry [2 ]
机构：
[1] Childrens Natl Med Ctr, Washington, DC 20010 USA
[2] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[3] Childrens Mem Hosp, Chicago, IL 60614 USA
[4] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [31] Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study
    DuBois, Steven G.
    Shusterman, Suzanne
    Ingle, Ashish M.
    Ahern, Charlotte H.
    Reid, Joel M.
    Wu, Bing
    Baruchel, Sylvain
    Glade-Bender, Julia
    Ivy, Percy
    Grier, Holcombe E.
    Adamson, Peter C.
    Blaney, Susan M.
    CLINICAL CANCER RESEARCH, 2011, 17 (15) : 5113 - 5122
  • [32] A PHASE 1 TRIAL OF THE HISTONE DEACETYLASE INHIBITOR PANOBINOSTAT IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY
    Cooney, Tabitha
    Onar-Thomas, Arzu
    Huang, Jie
    Lulla, Rishi
    Fangusaro, Jason
    Kramer, Kim
    Baxter, Patricia
    Fouladi, Maryam
    Dunkel, Ira J.
    Warren, Katherine E.
    Monje, Michelle
    NEURO-ONCOLOGY, 2018, 20 : 53 - 53
  • [33] Phase I study of fotemustine in pediatric patients with refractory brain tumors
    Hargrave, DR
    Bouffet, E
    Gammon, J
    Tariq, N
    Grant, RM
    Baruchel, S
    CANCER, 2002, 95 (06) : 1294 - 1301
  • [34] Phase I study of everolimus in pediatric patients with refractory solid tumors
    Fouladi, Maryam
    Laningham, Fred
    Wu, Jianrong
    O'Shaughnessy, Melinda A.
    Molina, Kristen
    Broniscer, Alberto
    Spunt, Sheri L.
    Luckett, Inga
    Stewart, Clinton F.
    Houghton, Peter J.
    Gilbertson, Richard J.
    Furman, Wayne L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4806 - 4812
  • [35] Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors
    Schuelke, Matthew R.
    Gundelach, Justin H.
    Coffey, Matt
    West, Emma
    Scott, Karen
    Johnson, Derek R.
    Samson, Adel
    Melcher, Alan
    Vile, Richard G.
    Bram, Richard J.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [36] A phase I trial of MK-0752 in children with recurrent or refractory CNS malignancies: A Pediatric Brain Tumor Consortium study
    Fouladi, M.
    Olson, J.
    Stewart, C. F.
    Kocak, M.
    Gajjar, A. J.
    Demuth, T.
    Goldman, S.
    Kun, L. E.
    Boyett, J. M.
    Gilbertson, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: A children's oncology group study
    Horton, Terzah M.
    Thompson, Patrick A.
    Berg, Stacey L.
    Adamson, Peter C.
    Ingle, Ashish M.
    Dolan, M. Eileen
    Delaney, Shannon M.
    Hedge, Madhuri
    Weiss, Heidi L.
    Wu, Meng-Fen
    Blaney, Susan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) : 4922 - 4928
  • [38] Phase Ib study of PTC299, a novel oral inhibitor of tumor VEGF expression, in patients with advanced cancer.
    Schwartz, G. K.
    Dickson, M. A.
    Callahan, L. A.
    Darby, C. H.
    Llorente, M.
    Cao, Y.
    Dials, H. J.
    Miller, L. L.
    Miao, H. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] A phase I study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
    Cash, Thomas
    Jonus, Hunter C.
    Tsvetkova, Maya
    Beumer, Jan Hendrik
    Lee, Jasmine Y.
    Henry, Curtis
    Aguilera, Dolly
    Harvey, R. Donald
    Goldsmith, Kelly C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Phase I study of regorafenib in combination with vincristine and irinotecan in pediatric patients with recurrent or refractory solid tumors.
    Casanova, Michela
    Bautista, Francisco
    Hewson, Quentin Campbell
    Makin, Guy
    Marshall, Lynley V.
    Verschuur, Arnauld
    Canete, Adela
    Corradini, Nadege
    Ploeger, Bart
    Mueller, Udo
    Zebger-Gong, Hong
    Chung, John Woojune
    Geoerger, Birgit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345